PreprintCited by 121SARS-CoV-2 detection and testingSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Amplicon based MinION sequencing of SARS-CoV-2 and metagenomic characterisation of nasopharyngeal swabs from patients with COVID-19.

Open access
Moore, Shona C., Penrice-Randal, Rebekah, Alruwaili, Muhannad, Dong, Xiaofeng, Pullan, Steven T., Carter, Daniel P., Bewley, Kevin, Zhao, Qin +22 more·2020·Viruses

Abstract

COVID-19 is a complex disease phenotype where the underlying microbiome could influence morbidity and mortality. Amplicon and metagenomic MinION based sequencing was used to rapidly (within 8 hours) identify SARS-CoV-2 and assess the microbiome in nasopharyngeal swabs obtained from patients with COVID-19 by the ISARIC 4C consortium.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2020.03.05.20032011

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The nasopharyngeal bacterial population of COVID-19 patients varied with the length of viral infection.

    “Metagenomic sequencing has found that the nasopharyngeal bacterial population of COVID-19 patients varied with the length of viral infection.”

    From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Moore et al., 2020

  • Fusobacterium periodonticum significantly decreased 3 days after infection in COVID-19 patients.

    “For example, Fusobacterium periodonticum significantly decreased 3 days after infection (Moore et al., 2020).”

    From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Moore et al., 2020

  • In patients infected by SARS-CoV-2, Fusobacterium periodonticum significantly decreased in the nasopharynx, while in the gut, the proportion of probiotics (like Bifidobacterium, Lactobacillus, and Eubacterium) was significantly reduced, and the proportion of conditioned pathogenic bacteria was significantly increased, such as Corynebacterium and Ruthenibacterium, which could lead to microbial tran

    “What’s more, the imbalance of microbiota was also found in patients infected by SARS-CoV-2, Fusobacterium periodonticum significantly decreased in the nasopharynx (Moore et al., 2020),while in the gut, the proportion of probiotics (like Bifidobacterium, Lactobacillus, and Eubacterium) was significantly reduced, and the proportion of conditioned pathogenic bacteria was significantly increased, such”

    From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Moore et al., 2020

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Moore, S. C., Penrice-Randal, R., Alruwaili, M., Dong, X., Pullan, S. T., Carter, D. P., Bewley, K., Zhao, Q., Sun, Y., Hartley, C., Zhou, E.-M., Solomon, T., Beadsworth, M. B. J., Cruise, J., Bogaert, D., Crook, D. W., Matthews, D. A., Davidson, A. D., Mahmood, Z., Aljabr, W., Druce, J., Vipond, R. T., Ng, L. F. P., Renia, L., Openshaw, P. J. M., Baillie, J. K., Carroll, M. W., Semple, M. G., Turtle, L., & Hiscox, J. A.
Affiliations
  • University of Liverpool (GB)
  • Public Health England (GB)
  • Northwest A&F University (CN)
  • Liverpool University Hospitals NHS Foundation Trust (GB)
  • University of Oxford (GB)
  • University of Bristol (GB)
  • Peter Doherty Institute (AU)
  • Agency for Science, Technology and Research (SG)
  • Imperial College London (GB)
  • Roslin Institute (GB)
Corresponding author
  • Turtle, Lance
  • Hiscox, Julian A.
Venue
Viruses
Publisher
openRxiv
Published
2020-03-08
Volume
12
Issue
10
Pages
1164-1164
ISSN
1999-4915 (ISSN-L)
OpenAlex
W3092684668
Cited by
121
References
33
Citations by year
2026: 2 · 2025: 5 · 2024: 9 · 2023: 15 · 2022: 27 · 2021: 36 · 2020: 27
FWCI
3.44
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Viruses (publishedVersion, cc-by)
  • medRxiv (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
Funders
  • Wellcome Trust (205228/Z/16/Z)
  • National Institute for Health Research Health Protection Research Unit
  • National Institute for Health and Care Research (IS-HPU-1112−10117, CO-CIN-01, CL-2013-07-005, NF-SI-0514-10177, NF-SI-0513-10150)
  • University of Liverpool
  • Public Health England (205228/Z/16/Z)
  • King Fahad Medical City (019-003)
  • Hamilton Health Sciences Foundation
  • U.S. Food and Drug Administration (HHSF223201510104C)
  • Medical Research Council (MR/R502121/1, 1991596, MC_PC_19025, COVID-19)
  • Biotechnology and Biological Sciences Research Council (BB/M02542X/1)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords
SARS-CoV-2, COVID-19 pandemic, viral genome sequencing, Oxford Nanopore MinION, interferon antagonism, viral recombination, nasopharyngeal swab, false negative detection, molecular epidemiology
MeSH terms
Betacoronavirus, COVID-19, SARS-CoV-2, COVID-19 Vaccines, COVID-19 Testing, DNA, Viral, Humans, Pneumonia, Viral, RNA, Viral, Genome, Viral, Sequence Analysis, Molecular Epidemiology, DNA, Complementary, Coronavirus Infections, Clinical Laboratory Techniques, Pandemics, High-Throughput Nucleotide Sequencing, Multiplex Polymerase Chain Reaction, Real-Time Polymerase Chain Reaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review